BNP Paribas Financial Markets’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$417K Sell
152,340
-61,325
-29% -$194K ﹤0.01% 3684
2025
Q4
$791K Sell
213,665
-143,693
-40% -$464K ﹤0.01% 3274
2025
Q3
$947K Buy
357,358
+334,789
+1,483% +$648K ﹤0.01% 3174
2025
Q2
$22.2K Sell
22,569
-249,042
-92% -$249K ﹤0.01% 4553
2025
Q1
$391K Buy
271,611
+118,399
+77% +$218K ﹤0.01% 3319
2024
Q4
$337K Buy
153,212
+29,879
+24% +$69.7K ﹤0.01% 3551
2024
Q3
$203K Buy
123,333
+74,522
+153% +$150K ﹤0.01% 3250
2024
Q2
$108K Buy
48,811
+32,975
+208% +$77.6K ﹤0.01% 3268
2024
Q1
$42.4K Sell
15,836
-8,022
-34% -$19.5K ﹤0.01% 3588
2023
Q4
$71.3K Sell
23,858
-151,615
-86% -$197K ﹤0.01% 3484
2023
Q3
$172K Sell
175,473
-21,190
-11% -$30.7K ﹤0.01% 3148
2023
Q2
$273K Buy
196,663
+45,740
+30% +$63.9K ﹤0.01% 2900
2023
Q1
$240K Buy
150,923
+81,614
+118% +$421K ﹤0.01% 3076
2022
Q4
$432K Buy
69,309
+39,900
+136% +$285K ﹤0.01% 2671
2022
Q3
$197K Buy
29,409
+5,182
+21% +$35.6K ﹤0.01% 3497
2022
Q2
$154K Buy
24,227
+19,779
+445% +$112K ﹤0.01% 3196
2022
Q1
$20.6K Sell
4,448
-1,354
-23% -$5.81K ﹤0.01% 3719
2021
Q4
$29K Sell
5,802
-248,972
-98% -$1.99M ﹤0.01% 3816
2021
Q3
$3.07M Buy
254,774
+253,754
+24,878% +$3.69M 0.01% 1613
2021
Q2
$21.6K Sell
1,020
-1,997
-66% -$48.1K ﹤0.01% 3513
2021
Q1
$84.6K Buy
3,017
+63
+2% +$1.86K ﹤0.01% 3421
2020
Q4
$76.8K Sell
2,954
-63,086
-96% -$1.89M ﹤0.01% 3345
2020
Q3
$2.45M Buy
66,040
+61,592
+1,385% +$2.44M 0.01% 1415
2020
Q2
$228K Sell
4,448
-9,279
-68% -$388K ﹤0.01% 2438
2020
Q1
$433K Sell
13,727
-53,699
-80% -$2.83M ﹤0.01% 2427
2019
Q4
$4.02M Buy
67,426
+63,383
+1,568% +$2.85M 0.02% 1312
2019
Q3
$148K Buy
4,043
+1,182
+41% +$46.8K ﹤0.01% 2906
2019
Q2
$133K Sell
2,861
-2,184
-43% -$103K ﹤0.01% 2862
2019
Q1
$203K Buy
5,045
+3,745
+288% +$168K ﹤0.01% 2695
2018
Q4
$59.8K Sell
1,300
-373
-22% -$18K ﹤0.01% 2627
2018
Q3
$74.2K Buy
1,673
+81
+5% +$3.72K ﹤0.01% 2897
2018
Q2
$62.4K Sell
1,592
-24,138
-94% -$1.22M ﹤0.01% 3022
2018
Q1
$1.86M Buy
25,730
+22,131
+615% +$1.63M 0.01% 1420
2017
Q4
$237K Sell
3,599
-197,877
-98% -$10.7M ﹤0.01% 2881
2017
Q3
$10.1M Buy
201,476
+199,890
+12,603% +$9.64M 0.03% 582
2017
Q2
$73.4K Buy
1,586
+1,509
+1,960% +$55.5K ﹤0.01% 2980
2017
Q1
$2.72K Sell
77
-166
-68% -$3.8K ﹤0.01% 3454
2016
Q4
$3.04K Sell
243
-729
-75% -$8.68K ﹤0.01% 3845
2016
Q3
$13.5K Buy
972
+407
+72% +$4.61K ﹤0.01% 3089
2016
Q2
$5.58K Buy
+565
New +$9.36K ﹤0.01% 3222
2016
Q1
Sell
-3,816
Closed -$84.9K 2795
2015
Q4
$84.9K Buy
3,816
+961
+34% +$24.2K ﹤0.01% 2445
2015
Q3
$67.3K Sell
2,855
-19,027
-87% -$1.19M ﹤0.01% 2651
2015
Q2
$1.79M Buy
21,882
+21,737
+14,991% +$2.13M 0.01% 907
2015
Q1
$13.4K Buy
+145
New +$9.36K ﹤0.01% 2579
2014
Q4
Sell
-415
Closed -$10.2K 2359
2014
Q3
$10.2K Buy
415
+142
+52% +$2.26K ﹤0.01% 3580
2014
Q2
$4.32K Buy
273
+253
+1,265% +$3.65K ﹤0.01% 2659
2014
Q1
$276 Buy
20
+8
+67% +$124 ﹤0.01% 3161
2013
Q4
$165 Buy
+12
New +$175 ﹤0.01% 4032

Other funds holding ESPR